neurology
Esaote presents new MRI system to support brain glioma surgeries
October 7, 2025Research and Development Esaote, MRI, medical imaging, neurology
Gliomas are among the most common primary malignant brain tumours
Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth
July 16, 2025Research and Development CEO, Corporate, Neurology, Oncology, jazz pharmaceuticals, neurology, neuroscience
Jazz Pharmaceuticals has named Renée Galá as its next chief executive officer (CEO), effective 11 August 2025. Galá, currently president …
Abbvie acquires Cerevel Therapeutics
August 2, 2024Mergers and Acquisitions AbbVie, Cerevel Therapeutics, Drug-Resistant Epilepsy, Neurology, Parkinson's disease, major depressive disorder, mergers & acquisitions, neurology, neuroscience, schizophrenia
Abbvie has announced the acquisition of Cerevel Therapeutics, strengthening its neuroscience pipeline. Cerevel has multiple programmes across neurological and psychiatric …
Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder
April 22, 2024Research and Development Kaerus Bioscience, Neurolentech, Neurology, neurodevelopmental disorders, neurology
Neurolentech has announced that it has entered into a technology access partnership with Kaerus Bioscience, with the aim of driving …
BioIVT acquires PrecisionMed for neurology and oncology research
July 21, 2023Sales and Marketing Neurology, Oncology, neurology, oncology
BioIVT has announced that it has acquired PrecisionMed, a leading supplier of high-quality human biological material for genetics, drug discovery …
Cartesian Therapeutics announces successful trial of RNA cell therapy in autoimmunity
June 23, 2023Research and Development Cartesian Therapeutics, Neurology, RNA, autoimmune, neurology
Clinical stage biotechnology company, Cartesian Therapeutics, has announced results from its clinical trial using RNA CAR T (rCAR T) therapy …
Nido Biosciences raises $109m in funding for neurological diseases treatments
May 16, 2023Sales and Marketing Financing, Neurology, Nido Biosciences, funding, neurology
US-based clinical-stage company Nido Biosciences has announced that is has received $109m in Seed, Series A and Series B financings, …
AstraZeneca’s Ultomiris approved in EU for adults firm NMOSD
May 11, 2023Medical Communications AstraZeneca, NMOSD, Neurology, Ultomiris, neurology
AstraZeneca has announced the approval of Ultomiris (ravulizumab) in the European Union (EU) for the treatment of adult patients with …
FDA approves MS drug for human trials
January 27, 2020Sales and Marketing MS, MS symptoms, MS treatment, Neuro, neurology
A drug that can make it easier to diagnose Multiple Sclerosis (MS) has been approved for its first human trials …
British scientist develops technology able to deliver drugs directly into the brain
February 27, 2019Research and Development device, medical technology, neurology, neuroscince, parkinson's cns
A British scientist has developed innovative technology that is able to deliver drugs deep into the brain in order to …
Vitamin D deficiency may cause cognitive decline through weakening brain’s scaffolding
February 26, 2019Manufacturing and Production NPP, mental health, neurology, neuroscience, schizophrenia, vitamin d
Vitamin D deficiency may weaken supportive ‘scaffolding’ in the brain thus causing neurons difficulty in maintaining connections, according to a …
Mayor of London announces Takeda, UCL R&D partnership
October 14, 2015Research and Development London, R&D, Takeda, UCL, neurology
Takeda is teaming up with researchers at University College London (UCL) to identify and validate novel target genes for the …
Neurimmune kicks off late-stage Alzheimer’s study
September 9, 2015Research and Development Alzheimer's disease, Biogen, Neurimmune, aducanumab, neurology
Neurimmune and its development partner Biogen are beginning a Phase III study of the companies’ potential Alzheimer’s treatment aducanumab. The …
Neurology comes to the fore
September 7, 2015Manufacturing and Production, Research and Development, Sales and Marketing Alzheimer's disease, multiple sclerosis, neurology
Neurology is an area where pharma has struggled to deliver in recent years.Yet the high unmet need for drugs to …
Amgen and Novartis partner on Alzheimer’s and migraine treatments
September 2, 2015Research and Development Alzheimer's disease, Amgen, Novartis, migraine, neurology, neuroscience
Amgen and Novartis have announced a global collaboration to develop neuroscience treatments in Alzheimer’s disease and migraine. The companies plan …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
